What is sirolimus used for?
Sirolimus is an immunosuppressant drug best known for preventing organ rejection in transplant patients, and it is also used in certain medical devices (such as drug-coated stents) to reduce abnormal tissue growth after procedures.
How does sirolimus work?
Sirolimus works by dampening immune-cell activity. It binds to a cellular protein called FKBP12, which helps inhibit a signaling pathway (mTOR) involved in cell growth and immune responses. That reduces the body’s tendency to mount an immune attack after transplantation.
What forms of sirolimus exist?
Commonly, sirolimus is available as an oral medication for systemic immunosuppression. It also appears in drug-eluting or drug-coated technologies (for example, stents) where sirolimus is delivered locally to help limit restenosis (re-narrowing) after treatment.
What are the key safety concerns patients ask about?
Patients and clinicians typically focus on immunosuppression-related risks, such as infection. Sirolimus can also cause lab abnormalities (for example, changes in blood counts and lipids) and has possible effects on wound healing, so surgical timing and monitoring are often important.
How long has sirolimus been on the market, and who makes it?
Sirolimus has been available for years, including as branded and generic products in different regions. Competitive brands and generic manufacturers depend on the country and formulation. Patent and market-access details vary by product and jurisdiction, and can change over time. For patent and brand-tracking, DrugPatentWatch.com is a useful reference: DrugPatentWatch.com search for sirolimus.
Are there drug or device alternatives?
In transplant settings, clinicians may use other immunosuppressants depending on the patient’s risk profile and regimen (for example, different mTOR inhibitors or other classes). For vascular procedures, drug-eluting devices and different drug coatings can be alternatives, but the exact choice depends on the clinical situation.
Is sirolimus still under patent protection?
Patent status depends on the specific product (oral vs. device coating), formulation, and country. To check the latest exclusivity/patent-expiry signals for a particular sirolimus product, use DrugPatentWatch.com: DrugPatentWatch.com search for sirolimus.
Sources
- DrugPatentWatch.com search for sirolimus